The role of c-myc in regulating mdr1 gene expression in tumor cell line KB

Chinese Medical Journal

Volumn 113, Issue 9, 2000, Pages 848-851

  He, Ying ^a   Zhang, Jiren ^b   Zhang, Jian ^b   Yuan, Yawei ^b  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

c myc; Gene regulation; KB; mdr1; Multidrug resistance

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P; MESSENGER RNA; RIBOZYME; VINCRISTINE;

ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; ONCOGENE MYC; PHENOTYPE; PHYSIOLOGY; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; P-GLYCOPROTEIN; PHENOTYPE; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, CATALYTIC; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0034285894     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Knutsen T, Mickley LA, Ried T, et al. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractor ALL. Genes Chromosomes Cancer 1998;23:44-54.
2. Weintein RS, Jerome R, Kuszak P, et al. P-Gey-Co-Proteins in pathology: the multidrug resistant gene family in humans. Hum Pathol 1990;21:32-35.
3. Dietel M, Hartmut A, Lage H, et al. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPGS5-257. Cancer Res 1990;50:6100-6106.
4. Troussard X, Rimokh R, Valensi F, et al. Heterogeneity of t (1;19) (q23;p13) acute leukaemias. Br J Haematol 1995;89:516-526.
5. Komada Y, Zhou YW, Zhang XL, et al. Fas/APO-1 (CD95)-mediated cytotoxicity is responsible for the apoptotic cell death of leukemic cells induced by interleukin-2-activiated T cells. Br J Haematol 1997;96:147-157.
6. Jurgen S, Kirsten AW, Gunter B, et al. A simple method for the cytometric analysis of intracellular antigens in whole smooth muscle cells: quantification of cyclin-dependent kinase2. J Immunol Methods 1997;202:205-212.
7. Zhang J, Yuan YW, Zhang JR, et al. Investigation on the expression of N-GSLs in MDR tumor cell lines. Int J Modem Cancer Therapy 1998;1:81-82.
8. Cianfriglia M, Poloni F, Signoretti C, et al. Topology of MDR1-P-glycoprotein as indicated by epitope mapping of monoclonal antibodies to human MDR cells. Cytoectechnology 1996;19:247-251.
9. el-Deiry WS. Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr Opin Oncol 1997;9:79-87.
10. Motomura S, Motoji T, Takanashi M, et al. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides. Blood 1998;91:3163-3171.
11. Delaporte C, Dautry F, Sablon AJ, et al. Induction of pgp53 expression and reversion of the multidrug resistance phenotype in 9-OH-ellipticine-resistant Chinese hamster lung fibroblasts transfected with the MYC oncogene. Biochem Pharmacol 1997;53:59-66.